Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02325557
Title ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Patients With Prostate Cancer - KEYNOTE-046
Recruitment Completed
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Advaxis, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Recruiting San Francisco California United States Details
University of Colorado Health Sciences Center (UCHSC) Aurora Colorado United States Details
Recruiting Rockville Maryland United States Details
Recruiting Towson Maryland United States Details
New Brunswick New Jersey United States Details
Recrutiing Philadelphia Pennsylvania United States Details
Site Philadelphia Pennsylvania United States Details
Recruiting Providence Rhode Island United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field